<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Caspian Journal of Internal Medicine</title>
<title_fa></title_fa>
<short_title>Caspian J Intern Med</short_title>
<subject>Medical Sciences</subject>
<web_url>http://caspjim.com</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-6164</journal_id_issn>
<journal_id_issn_online>2008-6172</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.22088/cjim</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1402</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2023</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<volume>14</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Serologic evaluation of cytomegalovirus (CMV), 
Toxoplasma gondii and Brucella in schizophrenia patients</title>
	<subject_fa>psychiatry</subject_fa>
	<subject>psychiatry</subject>
	<content_type_fa>Original Article</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;line-height:14pt&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color:blue&quot;&gt;Background:&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;Infectious agents are considered as a possible cause of schizophrenia. The aim of this study was to evaluate the serum levels of cytomegalovirus (CMV), Toxoplasma gondii and Brucella antibodies in schizophrenia patients compared with the control group.&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:14pt&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color:blue&quot;&gt;Methods:&lt;/span&gt;&lt;/i&gt;&lt;/b&gt; This cross-sectional study was performed on 75 patients with schizophrenia who were clinically diagnosed with schizophrenia using the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) by two independent psychiatrists. As the controls, 75 sex and age-matched individuals were selected from orthopedic and surgical wards, who were admitted because of trauma. Anti-Toxoplasma gondii IgG antibody was detected by Abbott&amp;#39;s company diagnostic kit. To detect anti-Brucella IgG antibodies, the enzyme-linked immunosorbent assay (ELISA) test with Vircell diagnostic kit was used. Quantitative luminescence (CLIA) method using Abbott diagnostic kit was also used to detect anti-cytomegalovirus IgG antibody (CMV IgG avidity)&lt;span lang=&quot;EN&quot;&gt;. &lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:14pt&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color:blue&quot;&gt;Results:&lt;/span&gt;&lt;/i&gt;&lt;/b&gt; There was not any clinically significant differences in the mean value of Toxoplasma, CMV and Brucella IgG antibodies between schizophrenia and control group. However, considering cut-off point for these tests and further analysis with non-parametric tests showed clinically significant difference between two groups at cut-off point 1.1 for anti-Brucella IgG antibody which indicated more positive samples in schizophrenia group (24 out of 75) than control group (12 out of 75) with a p-value less than 0.05 (0.046)&lt;span lang=&quot;EN&quot;&gt;.&lt;/span&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color:blue&quot;&gt;&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:14pt&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color:blue&quot;&gt;Conclusion:&lt;/span&gt;&lt;/i&gt;&lt;/b&gt; The results of the present study showed no association between toxoplasmosis infection and CMV and schizophrenia. However, there might be a positive correlation between anti-Brucella IgG antibody and schizophrenia.&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color:#0033cc&quot;&gt;&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&amp;nbsp;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Schizophrenia, Serology, Cytomegalovirus, Brucellosis, Toxoplasmosis</keyword>
	<start_page>560</start_page>
	<end_page>566</end_page>
	<web_url>http://caspjim.com/browse.php?a_code=A-10-2614-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Seyed Shahab</first_name>
	<middle_name></middle_name>
	<last_name>Banihashem</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>shb_banihashem@yahoo.com</email>
	<code>100319475328460043077</code>
	<orcid>100319475328460043077</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of psychosomatic medicine, Taleghani Hospital Research Development Committee, Shahid Beheshti University of medical sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Forough</first_name>
	<middle_name></middle_name>
	<last_name>Yousefi Saber</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>yousefiforough2@gmail.com</email>
	<code>100319475328460043078</code>
	<orcid>100319475328460043078</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Psychiatry, Taleghani Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Somayeh</first_name>
	<middle_name></middle_name>
	<last_name>Motazedian</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>somayehmotazedian@yahoo.com</email>
	<code>100319475328460043079</code>
	<orcid>100319475328460043079</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of psychosomatic medicine, Taleghani Hospital Research Development Committee, Shahid Beheshti University of medical sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Masoud</first_name>
	<middle_name></middle_name>
	<last_name>Mardani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mmardani@sbmu.ac.ir</email>
	<code>100319475328460043080</code>
	<orcid>100319475328460043080</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Infectious Disease and Tropical Medicine Department, Faculty of Medicine of Shaheed Beheshti University of Medical Sciences and Health Services, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Alireza</first_name>
	<middle_name></middle_name>
	<last_name>Shamsi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ar.shamsi@sbmu.ac.ir</email>
	<code>100319475328460043081</code>
	<orcid>100319475328460043081</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of psychosomatic medicine, Taleghani Hospital Research Development Committee, Shahid Beheshti University of medical sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Maryam</first_name>
	<middle_name></middle_name>
	<last_name>Nazari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>maryamnazari79@gmail.com</email>
	<code>100319475328460043082</code>
	<orcid>100319475328460043082</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Neurology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Nastaran</first_name>
	<middle_name></middle_name>
	<last_name>Samani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>nastaransamani1990@yahoo.com</email>
	<code>100319475328460043083</code>
	<orcid>100319475328460043083</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Psychiatry, Taleghani Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Arash</first_name>
	<middle_name></middle_name>
	<last_name>Danesh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>arashdanesh1982@yahoo.com</email>
	<code>100319475328460043084</code>
	<orcid>100319475328460043084</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of psychosomatic medicine, Taleghani Hospital Research Development Committee, Shahid Beheshti University of medical sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
